Congress trades
Exelixis, Inc. (EXEL)
About Exelixis, Inc.
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Chief executive
- Michael Morrissey
- Employees
- 1,077
- Listed since
- Apr 17, 2000
- Market value
- $14.7B
- Price to earnings
- 17.7
- Earnings per share
- $3.43
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 3, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 5, 2026 | $0.91 | $0.85 | $628.7M | $636.4M | EPS beatRevenue in line |
| Q1 FY2026reported May 5, 2026 | $0.87 | $0.77 | $610.8M | $607.5M | EPS beatRevenue in line |
| Q4 FY2025reported Feb 10, 2026 | $0.94 | $0.77 | $598.7M | $596.5M | EPS beatRevenue in line |
| Q3 FY2025reported Nov 4, 2025 | $0.78 | $0.69 | $597.8M | $590.2M | EPS beatRevenue in line |
| Q2 FY2025reported Jul 28, 2025 | $0.75 | $0.65 | $568.3M | $594.9M | EPS beatRevenue miss |
| Q1 FY2025reported May 13, 2025 | $0.62 | $0.36 | $555.4M | $499.6M | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Apr 15, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Michael M. Morrissey, Ph.D.President and Chief Executive Officer | $1.3M | $30.5M | $1.4M | $33.2M |
| Christopher J. SennerExecutive Vice President and Chief Financial Officer | $823K | $9.3M | $482K | $10.6M |
| Dana T. Aftab, Ph.D.Executive Vice President, Research and Development | $659K | $9.5M | $408K | $10.5M |
| Patrick J. HaleyExecutive Vice President, Commercial | $621K | $8.1M | $338K | $9.0M |
| Brenda J. HeftiJ.D., Ph.D. Senior Vice President and General Counsel | $455K | $3.5M | $298K | $4.2M |
The summary compensation table from the 2025 proxy statement, current executives only. 2 executives who have since left the company are named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $1.6B | 29,075,377 | -5.6% | 11.59% |
| Farallon Capital Management LLC | $732.8M | 13,468,010 | +2.7% | 5.37% |
| Renaissance Technologies LLC | $730.6M | 13,427,993 | -2.2% | 5.35% |
| Vanguard Portfolio Management LLC | $655.3M | 12,043,122 | -0.3% | 4.80% |
| AQR Capital Management LLC | $598.6M | 11,023,943 | -15.8% | 4.40% |
| Vanguard Capital Management LLC | $595.8M | 10,950,997 | -2.7% | 4.37% |
| State Street Corp | $542.5M | 9,970,071 | -3.2% | 3.98% |
| Fuller & Thaler Asset Management, Inc. | $485.8M | 8,929,389 | +4.5% | 3.56% |
| LSV Asset Management | $443.3M | 8,146,478 | +5.2% | 3.25% |
| Geode Capital Management, LLC | $416.3M | 7,650,316 | -1.9% | 3.05% |
| D. E. Shaw & Co., Inc. | $302.1M | 5,551,747 | +54.1% | 2.21% |
| Morgan Stanley | $245.9M | 4,519,684 | +8.2% | 1.80% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in EXEL
6 disclosures of 6 on record · median 31d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +155.2%S&P +60.0% · vs S&P 500 +95.1% | Jan 10, 2024 | Feb 5, 2024 | 26d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +246.0%S&P +94.5% · vs S&P 500 +151.5% | Dec 6, 2022 | Jan 6, 2023 | 31d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +205.3%S&P +135.5% · vs S&P 500 +69.8% | Jan 8, 2020 | Feb 10, 2020 | 33d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +295.2%S&P +182.9% · vs S&P 500 +112.3% | Oct 25, 2018 | Nov 9, 2018 | 15d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +194.6%S&P +174.4% · vs S&P 500 +20.2% | Jun 15, 2018 | Jul 11, 2018 | 26d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +171.9%S&P +193.1% · vs S&P 500 -21.2% | Apr 3, 2018 | May 10, 2018 | 37d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded EXEL?
Ro Khanna disclosed EXEL transactions in the filings shown here.
How quickly are EXEL trades disclosed?
Congressional disclosures took a median of 31 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.